The U.S. Senate Committee on Finance has extended its probe of pharmaceutical industry educational grants by sending a letter of inquiry to the Accreditation Council for CME. The December 19 letter, available at, explains that the committee is continuing to review marketing practices that influence physicians’ prescribing patterns. In the letter to the ACCME, the senators said they are concerned that pharmaceutical companies use CME to deliver promotional messages. “There is a ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Senate Spotlights CME, you'll get exclusive access to a large archive of premium content.

Already registered? here.